Psoriatic arthritis (PsA) is a multifaceted disease, with a high impact on patients'
psychological and physical well-being. There is increasing recognition that assessment of …

Objective To provide an overview of commonly used outcome measure in psoriatic arthritis
(PsA). Background PsA is a heterogenous inflammatory arthritis, associated with psoriasis …

Psoriatic arthritis (PsA) is an inflammatory disease in patients with a personal or family
history of psoriasis. While synovitis is the major hallmark, enthesitis, dactylitis, axial …

Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical
phenotype. There has been considerable international collaboration over recent years to …

Objectives To develop a preliminary composite psoriatic disease activity index (CPDAI) for
psoriasis and psoriatic arthritis. Methods Five domains were assessed and specific …

This module reflected work within the Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) to develop and validate composite disease activity measures in …

Objective. To rank outcomes identified as important to patients with psoriatic arthritis (PsA)
and examine their representation in existing composite measures. Methods. Seven nominal …

Introduction The aim of this study was to evaluate the impact of comorbidities on disease
activity, patient's impact of the disease, patient global assessment, and function in psoriatic …

Psoriatic arthritis (PsA) is a highly heterogenous disease, with many different clinical
manifestations inside or outside of the musculoskeletal system and the skin. It is often …

ABSTRACT Psoriatic Arthritis (PsA) is a common condition that significantly impacts affected
patients. The introduction of novel therapeutic agents for PsA has generated considerable …